The levels of all of the BCR signalling-related genes (BTK, CARD11, BCL10, MALT1, and NFKB1 (p50)) were significantly increased in the DLBCL samples by approximately 1.2- or 2-fold. This evidence concerns the gene BTK and diffuse large B-cell lymphoma.